1. Home
  2. TWST vs LGND Comparison

TWST vs LGND Comparison

Compare TWST & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • LGND
  • Stock Information
  • Founded
  • TWST 2013
  • LGND 1987
  • Country
  • TWST United States
  • LGND United States
  • Employees
  • TWST N/A
  • LGND N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWST Health Care
  • LGND Health Care
  • Exchange
  • TWST Nasdaq
  • LGND Nasdaq
  • Market Cap
  • TWST 2.7B
  • LGND 2.3B
  • IPO Year
  • TWST 2018
  • LGND 1992
  • Fundamental
  • Price
  • TWST $49.23
  • LGND $114.25
  • Analyst Decision
  • TWST Buy
  • LGND Strong Buy
  • Analyst Count
  • TWST 9
  • LGND 6
  • Target Price
  • TWST $52.33
  • LGND $145.00
  • AVG Volume (30 Days)
  • TWST 802.1K
  • LGND 126.0K
  • Earning Date
  • TWST 01-31-2025
  • LGND 11-07-2024
  • Dividend Yield
  • TWST N/A
  • LGND N/A
  • EPS Growth
  • TWST N/A
  • LGND 160.46
  • EPS
  • TWST N/A
  • LGND 2.47
  • Revenue
  • TWST $312,974,000.00
  • LGND $152,422,000.00
  • Revenue This Year
  • TWST $21.67
  • LGND $26.86
  • Revenue Next Year
  • TWST $17.52
  • LGND $14.54
  • P/E Ratio
  • TWST N/A
  • LGND $45.87
  • Revenue Growth
  • TWST 27.69
  • LGND N/A
  • 52 Week Low
  • TWST $27.41
  • LGND $67.53
  • 52 Week High
  • TWST $60.90
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • TWST 55.41
  • LGND 46.35
  • Support Level
  • TWST $42.89
  • LGND $111.98
  • Resistance Level
  • TWST $49.75
  • LGND $117.54
  • Average True Range (ATR)
  • TWST 2.75
  • LGND 5.61
  • MACD
  • TWST -0.21
  • LGND -0.95
  • Stochastic Oscillator
  • TWST 57.49
  • LGND 19.28

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: